These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 2480428

  • 1. Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center.
    Cariati E, Brizzi L, Periti E.
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):72-6. PubMed ID: 2480428
    [Abstract] [Full Text] [Related]

  • 2. Triploidy identified through second-trimester serum screening.
    Huang T, Alberman E, Wald N, Summers AM.
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [Abstract] [Full Text] [Related]

  • 3. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
    Aitken DA, Crossley JA.
    Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of maternal serum alpha-fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.
    Brizzi L, Cariati E, Periti E, Nannini R, Torricelli F, Cappelli G, Gheri G.
    J Nucl Med Allied Sci; 1989 Apr; 33(3 Suppl):85-8. PubMed ID: 2480431
    [Abstract] [Full Text] [Related]

  • 5. Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus.
    Kramer RL, Yaron Y, O'Brien JE, Critchfield G, Ayoub M, Johnson MP, Qualls CR, Evans MI.
    Am J Med Genet; 1998 Jan 13; 75(2):176-8. PubMed ID: 9450880
    [Abstract] [Full Text] [Related]

  • 6. [Unusual behavior of serum markers in risk evaluation for trisomy 21].
    Guibaud S, Boisson C, Chambon V, Simplot A.
    Ann Biol Clin (Paris); 1998 Jan 13; 56(4):439-44. PubMed ID: 9754279
    [Abstract] [Full Text] [Related]

  • 7. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS, Haverkamp AD, Stark CF, Haverkamp C, Barth CK.
    J Matern Fetal Med; 1996 Jan 13; 5(2):70-3. PubMed ID: 8796771
    [Abstract] [Full Text] [Related]

  • 8. [Maternal serum alpha-fetoprotein as a screening test for fetal Down syndrome].
    Bessho T, Kanazawa R, Shiotani T, Mitsuo M, Koyama K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Mar 13; 47(3):237-43. PubMed ID: 7535328
    [Abstract] [Full Text] [Related]

  • 9. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB, Nikolenko MI, Khlevnaia LA, Fedotova OO, Solov'eva VD, Malova SA.
    Tsitol Genet; 1998 Mar 13; 32(1):66-71. PubMed ID: 9695254
    [Abstract] [Full Text] [Related]

  • 10. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].
    Thix J.
    Bull Soc Sci Med Grand Duche Luxemb; 1997 Mar 13; 134(1):25-9. PubMed ID: 9303823
    [Abstract] [Full Text] [Related]

  • 11. Maternal serum alpha-fetoprotein screening: benefits, risks, and costs.
    Campbell TL.
    J Fam Pract; 1987 Nov 13; 25(5):461-7. PubMed ID: 2445897
    [Abstract] [Full Text] [Related]

  • 12. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE.
    Obstet Gynecol; 1993 Jan 13; 81(1):72-7. PubMed ID: 7677967
    [Abstract] [Full Text] [Related]

  • 13. First-year results of routine alpha-fetoprotein testing on prenatal patients in a family practice.
    Weiss BD.
    J Fam Pract; 1988 Mar 13; 26(3):273-80. PubMed ID: 2450166
    [Abstract] [Full Text] [Related]

  • 14. Prenatal diagnosis policy without routine amniocentesis in pregnancies with a positive family history for neural tube defects.
    Papp Z, Tóth Z, Török O, Szabó M.
    Am J Med Genet; 1987 Jan 13; 26(1):103-10. PubMed ID: 2433941
    [Abstract] [Full Text] [Related]

  • 15. Risk prediction for Down's syndrome in young pregnant women using maternal serum biomarkers: determination of cut-off risk from receiver operating characteristic curve analysis.
    Hwa HL, Ko TM, Hsieh FJ, Yen MF, Chou KP, Chen TH.
    J Eval Clin Pract; 2007 Apr 13; 13(2):254-8. PubMed ID: 17378872
    [Abstract] [Full Text] [Related]

  • 16. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.
    Norem CT, Schoen EJ, Walton DL, Krieger RC, O'Keefe J, To TT, Ray GT.
    Obstet Gynecol; 2005 Oct 13; 106(4):747-52. PubMed ID: 16199631
    [Abstract] [Full Text] [Related]

  • 17. alpha-Fetoprotein screening.
    Burton BK.
    Adv Pediatr; 1986 Oct 13; 33():181-96. PubMed ID: 2432763
    [Abstract] [Full Text] [Related]

  • 18. Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.
    Haddow JE.
    Semin Perinatol; 1990 Dec 13; 14(6):488-503. PubMed ID: 1706536
    [No Abstract] [Full Text] [Related]

  • 19. [Screening by maternal serum markers for Down's syndrome].
    Liu JT, Hao N, Sun NH, Wang FY, Xu YH, Gai MY, Bian XM, Yang JQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr 13; 25(2):156-9. PubMed ID: 12905710
    [Abstract] [Full Text] [Related]

  • 20. Alpha-fetoprotein.
    Drugan A, Dvorin E, Obrien JE, Johnson MP, Evans MI.
    Curr Opin Obstet Gynecol; 1991 Apr 13; 3(2):230-4. PubMed ID: 1717020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.